ABSTRACT
Vaccination against hepatitis B virus (HBV) is effective at preventing mother-to-child transmission. Sierra Leone, Liberia and Guinea are hyperendemic West African countries; yet childhood immunization coverage is suboptimal and barriers to immunization are poorly understood. We analyzed national survey data (2018-2020) of children aged 4-35 months to assess full HBV immunization (receiving 3 doses of the pentavalent vaccine) and incomplete immunization (receiving < 3 doses). Statistical analysis was conducted using the complex sample command in SPSS (version 28). Multivariate logistic regression was used to identify determinants of incomplete immunization. Overall, 11181 mothers were analyzed (4846 from Sierra Leone, 2788 from Liberia and 3547 from Guinea). Sierra Leone had the highest HBV childhood immunization coverage (70.3%), followed by Liberia (64.5%) and Guinea (40.0%). Within countries, immunization coverage varied by sociodemographic characteristics (education, religion, household wealth index, access to mass media) and healthcare access (antenatal visits, place of delivery and health facility proximity). In multivariate regression analysis, Muslim mothers, lower household wealth index, < 4 antenatal visits, home delivery and distance to health facility were predictors of incomplete immunization (all p < 0.05). Addressing these socioeconomic and healthcare access barriers will be essential to help achieve the 2030 viral hepatitis elimination goals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocols for the DHS methodology and data collection procedures were approved by the institutional review boards or ethics committees at ICF Macro, the Sierra Leone Ethics and Scientific Review Committee, the University of Liberia Pacific Institute for Research and Evaluation, and the Guinea National Ethics Committee for Health Research (Comite National d'Ethique pour la Recherche en Sante). Written permission to use the respective country datasets was granted by the DHS.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript